GREY:CLAZF - Post by User
Post by
Chritterson Aug 30, 2021 4:23pm
111 Views
Post# 33782990
Must Read 2
Must Read 2On June 17, 2021, the Shareholders of the Company approved the transfer and sale to the former shareholders of Talent Biotechs Ltd. (“Talent”) of all assets of the Company’s program developing cannabidiol for the prevention and treatment of graft versus host disease (“GVHD”) in consideration for the release and discharge by the former shareholders of Talent of all existing obligations that the Company and its subsidiaries have to such former shareholders of Talent. According to the agreement, there are certain conditions for the closing: • Former Talent shareholders' satisfaction with the ruling from the Israeli Tax Authorities; • Former Talent shareholders' confirmation that all required reporting have been performed, including reports to the Israeli Registrar regarding the Talent's pledges; • Former Talent shareholders confirmation that all information set forth in section 1 regarding the share capital of Talent is accurate; • The receipt by the Company of the required stock exchange and shareholders’ approval as applicable; As of August 31, 2021, certain conditions have not been fulfilled, therefore, closing of the transaction has not occurred.